Peptide therapeutics and the pharmaceutical industry: barriers encountered translating from the laboratory to patients

J Rafferty, H Nagaraj, AP McCloskey… - Current medicinal …, 2016 - ingentaconnect.com
Peptides are receiving increasing interest as clinical therapeutics. These highly tunable
molecules can be tailored to achieve desirable biocompatibility and biodegradability with …
被引用次数：76 相关文章

[引用][C] Peptide therapeutics and the pharmaceutical industry: barriers encountered translating from the laboratory to patients.

J Rafferty, H Nagaraj, AP McCloskey… - Current Medicinal …, 2016 - eprints.ncl.ac.uk
Peptide therapeutics and the pharmaceutical industry: barriers encountered translating from
the laboratory to patients. - ePrints - Newcastle University Newcastle University Toggle Main …

Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating from the Laboratory to Patients

J Rafferty, H Nagaraj, AP McCloskey… - Current Medical …, 2016 - pure.qub.ac.uk
Peptides are receiving increasing interest as clinical therapeutics. These highly tunable
molecules can be tailored to biocompatibility and biodegradability with simultaneously …

[引用][C] Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating from the Laboratory to Patients

J Rafferty, H Nagaraj, AP McCloskey… - Current Medicinal …, 2016 - cir.nii.ac.jp
Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating
from the Laboratory to Patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating from the Laboratory to Patients.

J Rafferty, H Nagaraj, AP McCloskey… - Current Medicinal …, 2016 - europepmc.org
Peptides are receiving increasing interest as clinical therapeutics. These highly tunable
molecules can be tailored to achieve desirable biocompatibility and biodegradability with …

Peptide Therapeutics and the Pharmaceutical Industry: Barriers Encountered Translating from the Laboratory to Patients

J Rafferty, H Nagaraj, AP McCloskey… - Current medicinal …, 2016 - pubmed.ncbi.nlm.nih.gov
Peptides are receiving increasing interest as clinical therapeutics. These highly tunable
molecules can be tailored to achieve desirable biocompatibility and biodegradability with …